// App-Quantinova.ai

1005 : A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (Protocol MF07-01).

Researchers

Presenter

  • Atilla Soran

Principal Investigators

  • Serdar Ozbas

  • Hasan Karanlik

  • Mahmut Muslumanoglu

  • Abdullah Igci

  • Zafer Canturk

  • Zafer Utkan

  • Cihangir Ozaslan

  • Turkkan Evrensel

  • Cihan Uras

  • Erol Aksaz

  • Aykut Soyder

  • Umit Mustafa Ugurlu

  • Cavit Col

  • Neslihan Cabioglu

  • Betul Bozkurt

  • Efe Sezgin

  • Ronald Johnson

  • Barry C. Lembersky

Medical Centers

  • Department of Surgery, Division of Surgical Oncology Magee-Womens Hospital of UPMC, Pittsburgh, PA

  • Istanbul University, Istanbul, Turkey

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Istanbul University, Institute of Oncology, Istanbul, Turkey

  • General Surgery Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey

  • Department of General Surgery, Istanbul University, Istanbul, Turkey

  • Kocaeli University, Kocaeli, Turkey

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Uludag Univ, Pittsburgh, PA

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Istanbul Faculty of Medicine, University of Istanbul, Department of Surgery, Istanbul, Turkey

  • Federation of Breast Disease Associations, Ankara, Turkey

  • Magee-Womens Hospital of UPMC, Pittsburgh, PA

  • University of Pittsburgh, Pittsburgh, PA

Locations

  • United States

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • III

Study Id's

  • NCT00557986

Sponsors

  • N/A

Result

  • Final